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ABSTRACT
Aims Helicobacter pylori infection is the major cause of
peptic ulceration and gastric cancer, and an important
virulence determinant is its vacuolating cytotoxin vacA.
Previously, we have described allelic variation in vacA
which determines toxin activity and disease risk. Here we
aimed to quantify vacA mRNA expression in the human
stomach, deﬁne its genetic determinants and assess how
well it predicts gastric pathology.
Methods Gastric biopsies were donated by 39 patients
with H. pylori infection attending for endoscopy at
Queen’s Medical Centre, Nottingham, UK. Total RNA
was extracted, and vacA mRNA quantiﬁed by reverse
transcriptase quantitative PCR. Separate biopsies were
histologically scored for inﬂammation and atrophy using
the updated Sydney system. H. pylori strains were
isolated from further biopsies, and the nucleotide
sequence upstream of vacA determined.
Results vacA mRNA levels in human stomachs varied
by two orders of magnitude independently of vacA allelic
type. Among vacA i1-type (toxic) strains, increased vacA
expression was strongly associated with higher grade
gastric inﬂammation (p<0.02), neutrophil inﬁltration
(p<0.005) and the presence of atrophy (p<0.01).
A polymorphism at nucleotide +28 near the base of a
potential stem-loop structure within the 50 untranslated
region was signiﬁcantly associated with vacA transcript
level and inﬂammation.
Conclusions Increased gastric vacA expression during
H. pylori infection is associated with inﬂammation and
premalignant pathology. The +28 nucleotide within the
vacA 50 stem-loop stratiﬁes disease risk among toxic
vacA i1-type strains.
INTRODUCTION
Helicobacter pylori persistently colonises the
stomach of approximately half the world’s popula-
tion causing chronic gastritis, which usually
remains asymptomatic. However, some individuals
develop overt disease, such that H. pylori is the
leading cause of peptic ulcer disease (PUD),
mucosa-associated lymphoid tissue (MALT) lymph-
oma and distal gastric adenocarcinoma (GC).1
Given the prevalence of infection, H. pylori-related
gastric diseases are a major global health burden. In
2010, the estimated global deaths from PUD and
GC were 0.25 million and 0.75 million, respect-
ively.2 GC is estimated to be the third biggest cause
of cancer-related death worldwide.3 Determinants
of disease risk for a speciﬁc H. pylori-infected indi-
vidual include: the virulence of the infecting strain,
host factors such as gene polymorphisms and
immune response, and environmental factors such
as diet and smoking.1
Two importantH. pylori virulence factors strongly
associated with gastric and duodenal disease are the
cytotoxin associated gene A (cagA) and the vacuolat-
ing cytotoxin, VacA. The CagA protein is translo-
cated into host cells by a type IV secretion system
encoded on the cag pathogenicity island that is
present in about 70% of strains. Here it becomes
phosphorylated by Src-family kinases and interacts
with several host signalling factors, such as the
proto-oncogene SHP2, modulating important
cancer-related signalling pathways leading to
increased cell proliferation and motility, as well as
the expression of pro-inﬂammatory cytokines via the
activation of nuclear factor kappa-light-chain-enhan-
cer of activated B cells (NF-κB).4 Transgenic mice
expressing CagA protein develop gastrointestinal
and haematopoietic neoplasms, directly demonstrat-
ing the oncogenic properties of this important viru-
lence determinant.5 VacA has many cellular effects
in vitro, including: inducing vacuolation of epithelial
cells, causing mitochondrial damage leading to
apoptosis; reducing transepithelial resistance; inhi-
biting T cell proliferation; and activating mitogen-
activated protein (MAP) kinase pathways.6 It also
causes epithelial damage when given orally to mice.7
Many of these effects depend on VacA forming
anion-selective channels in cell membranes.6
The vacA gene is present in all H. pylori strains,
and virtually all produce VacA protein; however,
not all are fully cytotoxic. While vacA is generally
well conserved, three regions with signiﬁcant allelic
diversity exist: the signal region (s1/s2), the mid-
region (m1/m2) and the intermediate region
(i1/i2).8 9 Mosaicism occurs such that all forms of
the toxin exist, although some alleles are rare.
Functionally, the signal and intermediate regions
determine toxin activity: s1i1 forms are fully active
while s1i2 and s2i2 forms are less so. The vacuolat-
ing activity of s2 forms is blocked by an N-terminal
extension to the mature toxin.10–12 Mutagenesis
studies show that the intermediate region is a direct
determinant of toxin activity, but the underlying
mechanism remains undetermined.9
In Western Europe and the USA, where vacA
allelic diversity is common, s1m1 strains are asso-
ciated with more gastric inﬂammation, PUD and
GC.6 Recently, the vacA i1 genotype has been
shown to be an even better marker of gastric
disease risk, as expected given that it is a direct
determinant of toxicity.9 13 However, these associa-
tions are not absolute, and in some populations,
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particularly in East Asia, most H. pylori strains are vacA i1-type,
making the intermediate region an unsuitable disease marker in
such areas.14 15
vacA transcription varies between H. pylori strains grown in
vitro.16 17 We hypothesised that the amount of VacA produced
during infection, as well as its activity, would have important
implications for disease. We aimed to quantify vacA transcript
levels in gastric biopsies from patients with H. pylori infection,
correlate this with inﬂammation, atrophy and intestinal metapla-
sia, and identify genetic determinants of vacA expression which
may be additional markers of disease risk.
MATERIALS AND METHODS
Bacterial strains
H. pylori strains were grown on blood agar base 2 plates supple-
mented with 5% horse blood (Oxoid, Basingstoke, UK) for
24–48 h at 37°C under humid, microaerobic conditions in a
MACS-VA500 workstation (Don Whitley Scientiﬁc, Shipley,
UK). Clinical H. pylori isolates were genotyped for vacA allelic
type and cagA status by PCR as previously described.9
Patient samples
Corporal gastric biopsies were donated by 39 patients with
H. pylori infection (median age 56 years, range 30–82 years;
51% male) attending the Queen’s Medical Centre, Nottingham,
UK, for routine upper gastrointestinal endoscopy for dyspeptic
symptoms. Informed written consent and approval from the
Nottingham Research Ethics Committee 2 (08/H0408/195) was
obtained. Patients taking proton pump inhibitors, non-steroidal
anti-inﬂammatory drugs (NSAIDs), >150 mg/day of aspirin or
antibiotics 2 weeks preceding endoscopy were excluded.
Biopsies for isolation of H. pylori were immediately placed into
isosensitest broth (Oxoid) containing 15% (v/v) glycerol, and
then swabbed onto blood agar plates and cultured. For hist-
ology, formalin-ﬁxed corporal biopsies (two per patient to avoid
patchy changes) were parafﬁn-embedded, sectioned and stained
with H&E for assessment of inﬂammation and atrophy. Grading
was performed using updated Sydney scoring18 (0=not present,
1=mild, 2=moderate and 3=substantial) by an experienced
histopathologist (AMZ) blinded to other data. Histological
scores were representative of both corporal biopsies examined
for each patient. A single corporal biopsy for each patient was
taken for RNA analysis and immediately preserved in RNAlater
(Sigma-Aldrich, Poole, UK).
Nucleotide sequencing of the vacA–cysS intergenic region
Genomic DNA was extracted from clinical H. pylori isolates as
previously described.19 The vacA sequence from nucleotides
520–1055 (GenBank U05676), including the intergenic region
between vacA and the upstream gene cysS (cysteinyl-tRNA
synthetase), was PCR-ampliﬁed using primers DL120 and
VA1-R,8 and the product sequenced by the Biopolymer
Synthesis and Analysis Unit, University of Nottingham.
Sequences were aligned using MegAlign (DNAStar, Madison,
Wisconsin, USA). Nucleotide positions where three or more
strains differed to the consensus were deﬁned as polymorphic.
Reverse transcriptase quantitative PCR
Total RNA was puriﬁed from gastric biopsies using rotor-stator
homogenisation and an RNeasy Mini Kit (Qiagen, Manchester,
UK). Residual genomic DNA was removed by DNA-free DNase
treatment (Life Technologies, Paisley, UK). cDNA was reverse
transcribed from 200 ng RNA using an Omniscript reverse tran-
scriptase kit (Qiagen) and random hexamer primers (GE
Healthcare Life Sciences, Little Chalfont, UK). For each sample,
negative control reactions were prepared without reverse tran-
scriptase to conﬁrm the absence of genomic DNA. Triplicate
reverse transcriptase quantitative PCRs (RT-qPCRs) were per-
formed using a Quantitect SYBR Green PCR kit and a
Rotor-Gene 3000 real-time PCR system (both Qiagen). vacA
mRNA levels were calculated relative to a comparator biopsy
cDNA sample included in all experiments (arbitrarily assigned
an expression level of 100) using the Pfafﬂ method,21 normalis-
ing to the H. pylori reference gene 16S rRNA to correct for dif-
ferences in H. pylori density or sample amount. A 259 bp vacA
amplicon was ampliﬁed using primers VA1-F and VA1-R,8 and a
164 bp 16S rRNA amplicon ampliﬁed by primers 16S-rRNA-F
(50 CGATGAAGCTTCTAGCTTGC 30) and 16S-rRNA-R
(50 ATAGGACATAGGCTGATCTC 30). Thermocycling condi-
tions were: 95°C for 15 min followed by 35 cycles of 95°C for
30 s, 56°C for 60 s and 72°C for 30 s. No template controls
were included and melt curve analysis conﬁrmed ampliﬁcation
speciﬁcity. Primer efﬁciencies, calculated from serial dilutions of
the comparator sample, were 0.91 (R2=0.98) and 0.57
(R2=0.99) for vacA and 16S rRNA, respectively.
Statistical analysis
Associations between gastric vacA mRNA data and genotype,
histological data, disease type and promoter region polymorph-
isms were evaluated by Mann–Whitney U tests or by Kruskal–
Wallis analysis of variance (ANOVA) for multiple comparisons,
with multiplicity adjusted pairwise p values calculated by
Dunn’s test. Tests were performed using GraphPad Prism 6 soft-
ware, and two-tailed p values less than 0.05 were taken as being
statistically signiﬁcant.
RESULTS
H. pylori vacA expression in the human stomach varies
considerably between strains
While vacA allelic type is a major determinant of gastric cancer
risk among patients with H. pylori infection, the association is
imperfect, and we hypothesised that the amount of VacA pro-
duced by a strain may also be important. Reliable quantiﬁcation
of VacA production by H. pylori in the human stomach is ham-
pered by the lack of speciﬁc antibodies, so we aimed to assess
levels of vacA mRNA in gastric biopsies using RT-qPCR. We
quantiﬁed vacA mRNA in corporal gastric biopsies from 39
patients with H. pylori infection. vacA transcripts were detected
in biopsies from 21 patients, with levels varying from 0.1 to
46.8 relative vacA mRNA units. For the remaining 18 patients,
no vacA expression was detected in vivo. By assaying serially
diluted comparator sample cDNA, we determined our vacA
mRNA detection limit as being eightfold below the lowest posi-
tive value obtained from patient biopsies. Thus strains with
undetectable vacA mRNA have expression below this level.
The level of vacA expression in vivo does not correlate with
vacA type
We determined the vacA allelic type of each strain by PCR8 9 22
to assess whether this correlated with gastric vacA mRNA level.
Two patients were excluded because typing suggested the pres-
ence of multiple strains with different vacA types, leaving 37
patients in our analysis. There was no signiﬁcant difference in
relative vacA mRNA levels between toxic i1-type and non-toxic
i2-type strains (medians 0.93 (n=27) and 0.96 (n=10), respect-
ively, p=0.99, Mann–Whitney U test). There were only four
patients infected with s2-type strains, too few to compare signal
region types; however, one was a high- and two were low-level
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transcribers. Moreover, one had undetectable vacA mRNA. We
also assessed cagA status by PCR for all 39 infecting strains, and
again there was no association with relative gastric vacA mRNA
level (medians 0.93 for cagA+ strains (n=29) and 0.96 for
cagA- strains (n=10), p=0.47).
For toxic vacA i1-type strains, vacA mRNA levels in the
human stomach are closely associated with gastric
inﬂammation and precancerous change
Next, we assessed whether H. pylori vacA expression in the
stomach was associated with inﬂammation and precancerous
damage by scoring histological parameters using the updated
Sydney system.18 We previously showed that only i1-type strains
are actively toxic in vitro.9 In agreement with this, 8 of the 10
patients infected with i2-type strains had mild (grade 1) inﬂam-
mation and none had atrophy or intestinal metaplasia. Our
main interest was why i1-type strains have different associations
with inﬂammation and damage; so we limited subsequent ana-
lysis to 25 patients infected with i1-type strains for which hist-
ology samples could be located.
First we assessed the association between vacA expression and
‘chronic inﬂammation’ score, deﬁned by the density of mono-
nuclear inﬂammatory cells in the biopsy specimen. Median rela-
tive vacA mRNA level was signiﬁcantly higher in patients with
grade 3 inﬂammation than those with grade 1 inﬂammation
(p<0.02; ﬁgure 1A). Patients with grade 2 inﬂammation had
intermediate vacA mRNA levels. Seventeen patients had grade 1
or 2 neutrophil inﬁltration, referred to as ‘activity’ in the
Sydney system, eight had no activity (grade 0) and none had
grade 3 activity. Median relative vacA mRNA level for patients
with grade 2 activity was signiﬁcantly higher than for patients
with no neutrophil inﬁltration (grade 0; p<0.005); patients
with grade 1 activity were intermediate (ﬁgure 1C). Only six
patients had gastric atrophy, all grade 1. Median relative vacA
mRNA level was signiﬁcantly higher in patients with atrophy
than without (p<0.01; ﬁgure 1E). Only two patients had intes-
tinal metaplasia, insufﬁcient for statistical analysis; however,
their median relative vacA level was 6.5 compared with 0.0 for
the patients without intestinal metaplasia.
To avoid confounding effects from differences in vacA signal
and mid-region type, and cagA status, we next stratiﬁed our data
based on the 20 patients infected with vacA s1i1m1 cagA+
strains. We combined data for inﬂammation grades 2 and 3 to
avoid small group sizes. Median relative vacA mRNA level was
signiﬁcantly higher for patients with grade 2 or 3 inﬂammation
than grade 1 (p<0.05; ﬁgure 1B), and for patients with neutro-
phil inﬁltration than for those without (p<0.005; ﬁgure 1D).
Only three patients infected with vacA s1i1m1 cagA+ strains
had atrophy, too few for reliable statistical analysis (ﬁgure 1F).
The level of vacA transcription in vivo does not correlate
with PUD
Of the 39 patients studied, 27 had past or present gastric or
duodenal ulcers or erosions and were collectively deﬁned as a
PUD group. Only one patient had GC and was omitted from
this analysis. The remaining 11 patients showed no pathology
on endoscopy and were deﬁned as a normal group. There was
no signiﬁcant difference in median relative vacA mRNA level
between the PUD and normal groups (ﬁgure 2). However, our
study was not powered to detect such a difference. There
remained no signiﬁcant difference in median relative vacA
mRNA levels when comparing the 22 patients with active ulcers
and the normal group (medians 0.76 and 0.0, p=0.50).
In vivo vacA mRNA levels are not associated with promoter
polymorphisms, but are associated with a polymorphism in
a potential 50 stem-loop in the vacA transcript
Having shown that inﬂammation and premalignant disease were
associated with increased vacA mRNA among toxigenic, i1-type
strains, we considered it important to assess the genetic determi-
nants of high level vacA expression in vivo. We compared the
nucleotide sequence between vacA and the upstream gene cysS
for 27 strains to identify polymorphisms that correlated with
our gastric vacA mRNA data (see online supplementary ﬁgure
S1). Interestingly, 31/110 nucleotides in the vacA promoter
region (end of cysS to vacA transcriptional start site) were poly-
morphic compared with just 11/119 nucleotides in the 50
untranslated region (50 UTR) of the encoded transcript
(p=0.0003, Fisher’s exact test). In agreement with previous
studies,17 23 the vacA promoter had three polymorphisms: G/A/
T(−32) within the −35 motif; and G/T(−14) and G/T(−7)
within the extended −10 motif. Four polymorphisms were
observed within a previously identiﬁed imperfect inverted
repeat upstream of the −35 motif,17 with three strains having a
perfect inverted repeat. None of these, or the remaining poly-
morphisms within the promoter region, correlated with gastric
vacA mRNA level.
We recently described a second inverted repeat located
between +4 and +30 in the vacA 50 UTR, predicted to form a
stem-loop structure at the 50 end of the transcript (ﬁgure 3).24
We showed that this potential stem-loop is important for stabi-
lising vacA mRNA: disrupting its formation led to reduced
mRNA half-life and decreased steady-state vacA transcript
levels.24 At the third pairing position from the base, the 50 stem
is consistently thymine (uracil in mRNA) but the 30 pairing
nucleotide (position +28) can be either guanine (G(+28)) or
adenine (A(+28)), the latter potentially stabilising the stem-loop
more efﬁciently. In our previous work, we showed that substitut-
ing adenine for guanine at position +28 signiﬁcantly increased
vacA mRNA steady-state levels in two different strain back-
grounds.24 Here we report that strains possessing A(+28)
expressed more vacA in gastric biopsies than those with G(+28)
(p<0.01; ﬁgure 4A). Furthermore, i1-type strains with A(+28)
were associated with more inﬂammation (p<0.05; ﬁgure 4B)
and neutrophil inﬁltration (p<0.01; ﬁgure 4C) than those with
G(+28).
DISCUSSION
The vacuolating cytotoxin is a major virulence determinant of
H. pylori. Previously, we described vacA polymorphisms that
affect its toxicity and devised simple PCR-based typing systems
to identify these alleles among H. pylori strains.9–11 22
Subsequent vacA typing has shown that speciﬁc alleles, such as
s1- and i1-types, are robust markers of increased disease risk in
many Western populations.6 Here we show for the ﬁrst time
that in addition to differences in VacA toxicity between strains,
vacA expression during H. pylori infection of the human
stomach varies widely and is associated with the amount of
inﬂammation and atrophy present. Previous studies have shown
vacA expression varies widely between strains, but no correl-
ation with promoter region polymorphisms was observed:
sequence data were only reported for two strains studied by
Forsyth et al,16 and there was insufﬁcient variation at the +28
position in the 50 UTR of the strains studied by Ayala et al17 to
show the same association with vacA expression observed
among our strains. An important difference in our study is that
vacA mRNA levels were measured within gastric biopsies from
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patients with the infection, rather than from in vitro cultures of
isolated strains.
Despite many polymorphisms in the cysS–vacA intergenic
region, we found only one that associated with gastric vacA
mRNA expression, located at position +28 in the 50 UTR.
However, we cannot rule out that multiple polymorphisms
affect vacA expression and have confounding effects on each
other, masking any association with our expression data.
Candidate polymorphisms are those located at −32, −14 and
−7 within the promoter consensus sites. Indeed, replacing
guanine with thymine at position −14 reduces vacA transcrip-
tion twofold;23 so it is possible that the G/A polymorphism we
observed at this position would affect vacA mRNA levels when
assessed in an isogenic system.
It was interesting that the vacA 50 UTR was signiﬁcantly more
conserved than the upstream nucleotide sequence containing
the promoter sites. One explanation could be sequence con-
straints imposed by important secondary structure formation in
Figure 1 vacA mRNA level in the human stomach infected with Helicobacter pylori is associated with inﬂammation and atrophy. Gastric biopsies
were scored for inﬂammation (A and B), neutrophil inﬁltration (C and D) and atrophy (E and F) using the updated Sydney system by a qualiﬁed
histopathologist blind to all data. Relative vacA mRNA levels in separate gastric biopsies were quantiﬁed by reverse transcriptase quantitative PCRs
using the Pfafﬂ method21 with 16S rRNA as a reference gene (arbitrary units). Data were stratiﬁed by vacA i1-type (A, C and E; n=25) or vacA
s1i1m1, cagA+ genotype (B, D and F; n=20). Multiple comparisons for inﬂammation and neutrophil inﬁltration grades (A and C) were assessed by
Kruskal–Wallis analysis of variance (ANOVA) and multiplicity adjusted pairwise p values calculated by Dunn’s test are shown. Pairwise comparisons
(B and D–F) were assessed by Mann–Whitney U tests for statistical signiﬁcance.
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this untranslated mRNA region. Indeed, we have recently identi-
ﬁed a potential stem-loop structure from +4 to +30 in the vacA
50 UTR which we showed was important for stabilising the vacA
mRNA transcript.24 Interestingly, the only polymorphism signiﬁ-
cantly associated with gastric vacA mRNA level and inﬂamma-
tion, G/A(+28), was located within this stem-loop sequence. In
our previous work, site-directed mutagenesis was used to
replace guanine with adenine at +28 in the vacA 50 UTR of
strains 60190 and SS1, allowing more favourable pairing with
uracil at position +6 and potentially increasing the stability of
the stem-loop. We found that isogenic mutants with A(+28)
had signiﬁcantly higher steady-state levels of vacA mRNA than
their wild-type controls with G(+28).24 This supports our
current ﬁnding that clinical isolates with adenine at +28 are
associated with increased vacA mRNA level in gastric biopsies
from patients infected with H. pylori.
A recent study found vacA expression to be higher in patients
with gastric cancer than in those with non-atrophic gastritis or
duodenal ulcer.25 This agrees with our ﬁnding that higher vacA
Figure 2 Peptic ulcer disease (PUD) does not correlate with in vivo
vacA mRNA level. Pathological ﬁndings were recorded by a qualiﬁed
gastroenterologist during upper gastrointestinal endoscopy for
dyspeptic symptoms. Patients with past or present gastric or duodenal
ulcers or erosions were deﬁned as a PUD group. Patients showing no
pathology were deﬁned as normal. Patients taking proton pump
inhibitors or antibiotics in the 2 weeks preceding endoscopy were
excluded from the study. Relative vacA mRNA levels in gastric biopsies
were quantiﬁed by reverse transcriptase quantitative PCRs with 16S
rRNA as a reference gene (arbitrary units). Data were assessed by
Mann–Whitney U tests for statistical signiﬁcance.
Figure 3 A predicted stem-loop sequence is present near the start of
the vacA 50 untranslated region (UTR). (A) The intergenic region
between the 30 end of the upstream gene cysS (diagonal hatched box)
and the start of the vacA open reading frame (white box) is shown
with the −35 and −10 consensus promoter sequence positions, the
transcriptional start site (+1) and the 50 UTR (thick line) indicated. (B)
The predicted mRNA fold of a potential stem-loop sequence located at
+4 to +30 in the vacA 50 UTR, with a G/A polymorphism at position
+28 shown.
Figure 4 A natural G/A polymorphism within a potential stem-loop in
the vacA 50 untranslated region (UTR) is associated with in vivo vacA
mRNA level, inﬂammation score and neutrophil inﬁltration. The
nucleotide at position +28 in the vacA 50 UTR (A or G) was determined
by sequencing for the infecting strain from 27 patients. Gastric biopsies
were used to quantify the relative in vivo vacA mRNA level by reverse
transcriptase quantitative PCRs for all 27 patients (A), and scored for
inﬂammation (B) and neutrophil inﬁltration (C) using the Sydney system
for 19 patients infected with i1-type strains. Data were assessed by
Mann–Whitney U tests for statistical signiﬁcance.
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expression in the gastric mucosa is associated with increased
inﬂammation and the presence of atrophy. Therefore, the
disease risk of a patient with H. pylori infection is affected by
both the VacA type of the infecting strain and the level of vacA
expression during infection. This is important because the asso-
ciation between more active s1m1- and more recently i1-type
strains and PUD or GC is not absolute. Furthermore, in coun-
tries where most H. pylori strains are s1i1-type, these markers
of VacA toxicity do not allow differential determination of
disease risk. Our ﬁnding that a natural polymorphism at nucleo-
tide +28 of the vacA transcript affects vacA mRNA level shows
that speciﬁc naturally occurring polymorphisms may affect vacA
expression. This and other polymorphisms affecting vacA tran-
script levels may provide important additional markers for
determining which patients are at greatest risk of developing
severe gastric or duodenal disease, particularly among those
infected with more toxic vacA i1-type H. pylori strains.
Take home messages
▸ Expression of the Helicobacter pylori vacuolating cytotoxin
gene A (vacA) within the infected gastric mucosa varies
considerably between strains.
▸ The level of vacA mRNA expressed in vivo correlates with
gastric inﬂammation and premalignant pathology.
▸ A polymorphism at nucleotide +28 with the vacA 50
untranslated region of the transcript is associated with
gastric vacA expression level and inﬂammation, and may
provide an additional marker of disease risk.
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